USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Note: This document contains side effect information about rimantadine. Some of the dosage forms listed on this page may not apply to the brand name Flumadine.
Applies to rimantadine: oral tablet
Along with its needed effects, rimantadine (the active ingredient contained in Flumadine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking rimantadine:
Get emergency help immediately if any of the following symptoms of overdose occur while taking rimantadine:
Symptoms of overdose
Some side effects of rimantadine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to rimantadine: oral syrup, oral tablet
The more commonly reported adverse effects have included gastrointestinal and nervous system side effects.
Common (1% to 10%): Dizziness, headache, jitteriness
Uncommon (0.1% to 1%): Ataxia, somnolence
Frequency not reported: Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, convulsions, hypesthesia
Gait abnormality, hyperkinesia, tremor, taste loss/change, parosmia, and convulsions have been reported in less than 0.3% of patients. Hypesthesia has occurred with higher than recommended doses. Dizziness and headache were reported up to two times more often in geriatric patients receiving rimantadine than in those receiving placebo. Seizures were reported in a few patients during clinical trials with rimantadine. In two patients, seizure activity had been absent for greater than 10 years. However, their anticonvulsant medications had been withdrawn in the previous few months.
Common (1% to 10%): Nausea, vomiting, anorexia, dry mouth, abdominal pain
Uncommon (0.1% to 1%): Diarrhea, dyspepsia
Frequency not reported: Constipation, dysphagia, stomatitis
Constipation, dysphagia, and stomatitis have occurred with higher than recommended doses of rimantadine. Gastrointestinal symptoms (particularly nausea, vomiting, and abdominal pain) were reported at least twice as often in geriatric patients receiving rimantadine than in those receiving placebo. Tolerance may be improved by giving the drug in two divided daily doses.
Common (1% to 10%): Insomnia, impaired concentration, nervousness, depression
Uncommon (1% to 10%): Agitation
Frequency not reported: Hallucinations, euphoria, anxiety, confusion
Frequency not reported: Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, syncope
Cardiac failure, cerebrovascular disorder, heart block, hypertension, palpitation, pedal edema, tachycardia, and syncope were reported in less than 0.3% of patients.
Uncommon (0.1% to 1%): Dyspnea
Frequency not reported: Bronchospasm, cough
Common (1% to 10%): Asthenia, fatigue
Uncommon (0.1% to 1%): Tinnitus
Frequency not reported: Fever, rigors
Uncommon (0.1% to 1%): Diaphoresis, rash
Frequency not reported: Nonpuerperal lactation, increased micturition frequency
Genitourinary side effects have included nonpuerperal lactation in less than 0.3% of patients. Increased micturition frequency has occurred with higher than recommended doses of rimantadine.
Frequency not reported: Lacrimation, eye pain
June 25, 2020
June 23, 2020
June 22, 2020
June 18, 2020
June 17, 2020
June 4, 2020